Back to Search
Start Over
Comparison of bone marrow dosimetry and toxic effect of high dose 131I-labeled monoclonal antibodies administered to man
- Source :
- Scopus-Elsevier
- Publication Year :
- 1989
- Publisher :
- Elsevier BV, 1989.
-
Abstract
- 131I-labeled monoclonal antibodies were used in therapeutic trials in two potentially useful clinical situations: disseminated melanoma (intravenously administered Fab fragments; 21 patients) and disseminated peritoneal adenocarcinomatosis (intraperitoneal injection of IgG; 5 patients). Acute toxicity observed is consistent with mild bone marrow suppression of acute radiation syndrome and the observed toxicity is dose related in a manner that conforms to the expected human response to total body irradiation. For single doses of both i.p. administered and intravenously administered 131I-labeled anti-tumor antibodies, 100 rad to red marrow, calculated by the absorbed dose fraction method (MIRD), appeared to be a threshold below which significant acute toxicity was unlikely.
- Subjects :
- Pathology
medicine.medical_specialty
medicine.drug_class
medicine.medical_treatment
Intraperitoneal injection
Adenocarcinoma
Pharmacology
Monoclonal antibody
Iodine Radioisotopes
Bone Marrow
Neoplasms
Humans
Medicine
Melanoma
Peritoneal Neoplasms
Radiotherapy
business.industry
Antibodies, Monoclonal
Acute Radiation Syndrome
General Medicine
Total body irradiation
Acute toxicity
medicine.anatomical_structure
Bone marrow suppression
Toxicity
Bone marrow
business
Subjects
Details
- ISSN :
- 08832897
- Volume :
- 16
- Database :
- OpenAIRE
- Journal :
- International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology
- Accession number :
- edsair.doi.dedup.....f8a8f76ca87b934db2da5a5c8f90899c